memantine vs bpc 157 TB 500 157: Comprehensive comparison of healing peptides Brain peptides in Alzheimer's disease

Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made

The severity profile matters more than the raw percentages

Reconstituting a non-sterile lyophilized powder with bacteriostatic saline does not sterilize it

The discontinuation rate due to adverse events was 6% for CagriSema versus 3.7% for placebo